Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: REVVITY HEALTH SCIENCES, INC.
Awarding agency: Department of Defense / Department of the Army
Funding agency: Department of Defense / Department of the Army
Period of performance: 2018-09-07 to 2022-09-30
Current total value of award: $23090
Description: VASOPRESSIN (TAMC), CORRECT INFORMATION FLAGGED AS ERRONEOUS PER THE CONTRACTING WRITING SYSTEM PDS VALIDATION REPORT.